Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Gross Profit: 2019-2023

Historic Gross Profit for Benitec Biopharma (BNTC) over the last 5 years, with Jun 2023 value amounting to $75,000.

  • Benitec Biopharma's Gross Profit was N/A to $7,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $123,000, marking a year-over-year change of. This contributed to the annual value of $75,000 for FY2023, which is 17.19% up from last year.
  • Per Benitec Biopharma's latest filing, its Gross Profit stood at $75,000 for FY2023, which was up 17.19% from $64,000 recorded in FY2022.
  • Benitec Biopharma's Gross Profit's 5-year high stood at $11.8 million during FY2019, with a 5-year trough of -$83,000 in FY2020.
  • For the 3-year period, Benitec Biopharma's Gross Profit averaged around $25,000, with its median value being $64,000 (2022).
  • Its Gross Profit has fluctuated over the past 5 years, first crashed by 100.71% in 2020, then soared by 200.00% in 2022.
  • Over the past 5 years, Benitec Biopharma's Gross Profit (Yearly) stood at $11.8 million in 2019, then slumped by 100.71% to -$83,000 in 2020, then rose by 22.89% to -$64,000 in 2021, then spiked by 200.00% to $64,000 in 2022, then grew by 17.19% to $75,000 in 2023.